Concepts (132)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Elastin | 8 | 2016 | 116 | 1.640 |
Why?
|
| Tissue Scaffolds | 9 | 2018 | 111 | 1.560 |
Why?
|
| Tissue Engineering | 8 | 2018 | 212 | 1.150 |
Why?
|
| Blood Vessel Prosthesis | 4 | 2018 | 182 | 1.140 |
Why?
|
| Bioprosthesis | 2 | 2018 | 101 | 1.110 |
Why?
|
| Collagen | 5 | 2016 | 636 | 0.950 |
Why?
|
| Mitral Valve | 2 | 2021 | 166 | 0.690 |
Why?
|
| Heart Valve Prosthesis | 2 | 2021 | 222 | 0.670 |
Why?
|
| Hydrolyzable Tannins | 3 | 2016 | 25 | 0.640 |
Why?
|
| Osteogenesis | 4 | 2019 | 152 | 0.600 |
Why?
|
| Diabetic Angiopathies | 1 | 2018 | 203 | 0.550 |
Why?
|
| Diabetes Mellitus | 2 | 2021 | 694 | 0.530 |
Why?
|
| Myocytes, Smooth Muscle | 4 | 2016 | 144 | 0.530 |
Why?
|
| Diabetes Mellitus, Experimental | 2 | 2019 | 195 | 0.510 |
Why?
|
| Extracellular Matrix | 6 | 2021 | 493 | 0.410 |
Why?
|
| Antioxidants | 1 | 2012 | 304 | 0.360 |
Why?
|
| Transforming Growth Factor beta1 | 3 | 2007 | 126 | 0.360 |
Why?
|
| Muscle, Smooth, Vascular | 2 | 2016 | 317 | 0.340 |
Why?
|
| Heart Valve Diseases | 2 | 2021 | 123 | 0.340 |
Why?
|
| Aortic Valve | 2 | 2021 | 249 | 0.330 |
Why?
|
| Core Binding Factor Alpha 1 Subunit | 2 | 2007 | 16 | 0.320 |
Why?
|
| Muscle, Smooth | 1 | 2007 | 117 | 0.290 |
Why?
|
| Fibroblasts | 4 | 2013 | 902 | 0.280 |
Why?
|
| Animals | 18 | 2021 | 20880 | 0.280 |
Why?
|
| Bone Morphogenetic Proteins | 1 | 2005 | 43 | 0.260 |
Why?
|
| Biocompatible Materials | 4 | 2013 | 247 | 0.260 |
Why?
|
| Swine | 6 | 2021 | 672 | 0.250 |
Why?
|
| Calcium | 2 | 2009 | 929 | 0.240 |
Why?
|
| Transforming Growth Factor beta | 2 | 2006 | 384 | 0.230 |
Why?
|
| Aorta | 2 | 2015 | 316 | 0.220 |
Why?
|
| Heart Valves | 3 | 2015 | 171 | 0.210 |
Why?
|
| Rats | 9 | 2013 | 5300 | 0.210 |
Why?
|
| Atherosclerosis | 2 | 2021 | 204 | 0.190 |
Why?
|
| Mitral Valve Insufficiency | 1 | 2021 | 99 | 0.180 |
Why?
|
| Diabetes Complications | 1 | 2021 | 249 | 0.180 |
Why?
|
| Heart Valve Prosthesis Implantation | 1 | 2021 | 164 | 0.170 |
Why?
|
| Rats, Sprague-Dawley | 6 | 2016 | 2083 | 0.150 |
Why?
|
| Stem Cells | 2 | 2016 | 248 | 0.150 |
Why?
|
| Cells, Cultured | 5 | 2016 | 2673 | 0.150 |
Why?
|
| Cross-Linking Reagents | 2 | 2014 | 80 | 0.140 |
Why?
|
| Mechanotransduction, Cellular | 1 | 2016 | 27 | 0.140 |
Why?
|
| Adipose Tissue | 1 | 2016 | 221 | 0.130 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2019 | 529 | 0.120 |
Why?
|
| Vascular Grafting | 1 | 2014 | 12 | 0.120 |
Why?
|
| Glucose | 1 | 2016 | 307 | 0.120 |
Why?
|
| Magnetite Nanoparticles | 1 | 2013 | 28 | 0.110 |
Why?
|
| Spheroids, Cellular | 1 | 2013 | 45 | 0.110 |
Why?
|
| Arteries | 1 | 2014 | 108 | 0.110 |
Why?
|
| Microvessels | 1 | 2013 | 43 | 0.110 |
Why?
|
| Cell Differentiation | 2 | 2007 | 1034 | 0.100 |
Why?
|
| Glycation End Products, Advanced | 1 | 2012 | 125 | 0.100 |
Why?
|
| Models, Biological | 1 | 2014 | 981 | 0.090 |
Why?
|
| Matrix Metalloproteinase 2 | 2 | 2007 | 145 | 0.090 |
Why?
|
| Phenols | 1 | 2009 | 73 | 0.080 |
Why?
|
| Flavonoids | 1 | 2009 | 109 | 0.080 |
Why?
|
| Inflammation Mediators | 2 | 2021 | 244 | 0.080 |
Why?
|
| Humans | 7 | 2021 | 68549 | 0.080 |
Why?
|
| Sus scrofa | 3 | 2014 | 74 | 0.080 |
Why?
|
| Up-Regulation | 2 | 2007 | 682 | 0.080 |
Why?
|
| Osteoprotegerin | 1 | 2007 | 11 | 0.080 |
Why?
|
| Skin | 2 | 2007 | 451 | 0.070 |
Why?
|
| Myocardium | 1 | 2013 | 1204 | 0.070 |
Why?
|
| Collagen Type I | 1 | 2007 | 175 | 0.070 |
Why?
|
| Guided Tissue Regeneration | 1 | 2005 | 6 | 0.070 |
Why?
|
| Biomarkers | 3 | 2021 | 1593 | 0.060 |
Why?
|
| Calcinosis | 1 | 2006 | 241 | 0.060 |
Why?
|
| Materials Testing | 3 | 2013 | 263 | 0.060 |
Why?
|
| Immunohistochemistry | 3 | 2013 | 1174 | 0.060 |
Why?
|
| Peptide Fragments | 1 | 2005 | 483 | 0.050 |
Why?
|
| Heptanoic Acids | 1 | 2002 | 28 | 0.050 |
Why?
|
| Male | 6 | 2019 | 37283 | 0.050 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2005 | 1745 | 0.050 |
Why?
|
| Hypercholesterolemia | 1 | 2002 | 86 | 0.050 |
Why?
|
| Pyrroles | 1 | 2002 | 83 | 0.050 |
Why?
|
| Disease Susceptibility | 1 | 2021 | 179 | 0.050 |
Why?
|
| Epithelial-Mesenchymal Transition | 1 | 2021 | 135 | 0.050 |
Why?
|
| Alloys | 1 | 2021 | 66 | 0.050 |
Why?
|
| Gene Expression Regulation | 1 | 2006 | 1293 | 0.040 |
Why?
|
| Mice, Knockout, ApoE | 1 | 2019 | 3 | 0.040 |
Why?
|
| Hyperglycemia | 1 | 2021 | 158 | 0.040 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2002 | 212 | 0.040 |
Why?
|
| Porosity | 2 | 2013 | 63 | 0.040 |
Why?
|
| Disease Management | 1 | 2021 | 248 | 0.040 |
Why?
|
| Time Factors | 2 | 2019 | 4655 | 0.040 |
Why?
|
| Prosthesis Design | 1 | 2021 | 301 | 0.040 |
Why?
|
| Coronary Stenosis | 1 | 2002 | 246 | 0.040 |
Why?
|
| Combined Modality Therapy | 1 | 2021 | 951 | 0.040 |
Why?
|
| Cell Adhesion Molecules | 1 | 2019 | 199 | 0.040 |
Why?
|
| Endothelial Cells | 1 | 2021 | 384 | 0.040 |
Why?
|
| Disease Models, Animal | 1 | 2006 | 2550 | 0.040 |
Why?
|
| Cardiac Catheterization | 1 | 2021 | 419 | 0.040 |
Why?
|
| Lipids | 1 | 2019 | 298 | 0.040 |
Why?
|
| Cell Proliferation | 2 | 2016 | 1174 | 0.040 |
Why?
|
| Hemodynamics | 1 | 2019 | 705 | 0.030 |
Why?
|
| Cell Shape | 1 | 2016 | 37 | 0.030 |
Why?
|
| Blood Glucose | 1 | 2019 | 631 | 0.030 |
Why?
|
| Stents | 1 | 2021 | 657 | 0.030 |
Why?
|
| Hypertrophy | 1 | 2016 | 89 | 0.030 |
Why?
|
| Muscle Proteins | 1 | 2016 | 94 | 0.030 |
Why?
|
| Microfilament Proteins | 1 | 2016 | 102 | 0.030 |
Why?
|
| Stress, Mechanical | 1 | 2016 | 208 | 0.030 |
Why?
|
| Implants, Experimental | 1 | 2014 | 15 | 0.030 |
Why?
|
| Magnetic Phenomena | 1 | 2013 | 12 | 0.030 |
Why?
|
| Heparin | 1 | 2014 | 205 | 0.030 |
Why?
|
| Rats, Wistar | 1 | 2014 | 371 | 0.030 |
Why?
|
| Basement Membrane | 1 | 2013 | 48 | 0.030 |
Why?
|
| Phenotype | 1 | 2016 | 946 | 0.030 |
Why?
|
| Vascular Patency | 1 | 2013 | 122 | 0.030 |
Why?
|
| Fibronectins | 1 | 2013 | 130 | 0.030 |
Why?
|
| Biomechanical Phenomena | 1 | 2013 | 368 | 0.020 |
Why?
|
| Cell Survival | 1 | 2013 | 901 | 0.020 |
Why?
|
| Coronary Vessels | 1 | 2013 | 313 | 0.020 |
Why?
|
| Bioreactors | 1 | 2010 | 65 | 0.020 |
Why?
|
| Polyphenols | 1 | 2009 | 34 | 0.020 |
Why?
|
| Collagenases | 1 | 2009 | 34 | 0.020 |
Why?
|
| Apoptosis | 1 | 2016 | 1641 | 0.020 |
Why?
|
| Cell Line | 1 | 2010 | 1752 | 0.020 |
Why?
|
| Sialoglycoproteins | 1 | 2006 | 24 | 0.020 |
Why?
|
| Osteopontin | 1 | 2006 | 28 | 0.020 |
Why?
|
| Alkaline Phosphatase | 1 | 2006 | 71 | 0.020 |
Why?
|
| Skin Physiological Phenomena | 1 | 2005 | 13 | 0.020 |
Why?
|
| Cell Polarity | 1 | 2005 | 49 | 0.020 |
Why?
|
| Capillaries | 1 | 2005 | 105 | 0.020 |
Why?
|
| Matrix Metalloproteinase 9 | 1 | 2006 | 160 | 0.020 |
Why?
|
| Cell Adhesion | 1 | 2005 | 324 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2006 | 710 | 0.010 |
Why?
|
| Macrophages | 1 | 2006 | 647 | 0.010 |
Why?
|
| RNA, Messenger | 1 | 2006 | 1663 | 0.010 |
Why?
|
| Heart | 1 | 2006 | 850 | 0.010 |
Why?
|
| Female | 2 | 2016 | 38021 | 0.010 |
Why?
|
| Middle Aged | 1 | 2002 | 21119 | 0.000 |
Why?
|
| Adult | 1 | 2002 | 21379 | 0.000 |
Why?
|